Jump to content

ECB 19th January (continued thread from December 2016)

Recommended Posts

euro-area-inflation-cpi.pngeuro-area-inflation-cpi (1).png

Above are 2 interesting charts inflation vs unemployment, but the second chart with brent and eu inflation shows an interesting correlation, (have not calculated, but relationship seems positively correlated). Therefore one could assume that if we see oil prices continue upwards, wage growth increase and a falling euro currency then tapering of the QE program will be on everyones radar. 

Link to comment

ECB: Pressure to taper but Draghi won't waver – HSBC


Research Team at HSBC notes that the Eurozone inflation is rising sharply, and the hawks might start asking for an early tapering of QE but Mr Draghi made a shrewd move in December, announcing an extension of QE to at least end-2017 and with underlying inflation subdued, HSBC doubt the ECB will be bowing to pressure just yet.

Key Quotes

“In December, Eurozone inflation climbed to 1.1% y-o-y, the highest level in over three years. There is more to come, and we think Eurozone inflation could reach 1.8% by February (even higher in some countries, such as Germany). With growth picking up, some of the more hawkish members of the ECB Governing Council may start to call for tapering QE as early as the 19 January meeting.”

“However, the majority of the Governing Council remain worried about muted underlying price pressures, despite the rise in headline inflation. Core and services inflation remain around 1%. As noted recently by ECB board member Ives Mersch – typically at the more hawkish end of the spectrum within the ECB Governing Council – wage growth is still too weak in the Eurozone. The ECB will also be wary of tightening monetary policy too soon, repeating the mistake of 2011 when it hiked rates, helping to curb the fragile recovery.”

“Perhaps anticipating the hawkish calls, the ECB announced in December a nine-month extension of QE – albeit at a slower purchase pace – until the end of 2017. At that time, although the oil price had already increased significantly, it was not yet reflected in the ECB inflation forecast, meaning it still projected a meaningful undershoot of its "close to but below 2%" target.”

“All in all, we think that the ECB will be on hold in January, and indeed in the coming months, looking through the inflation peak in the first half of next year before having to make a decision on the possible future of QE. And given that we think underlying inflation will remain stubbornly low, in our view QE will continue at EUR60bn per month until the end of the year, and then at a slower pace (EUR40bn per month) from January 2018.”

Link to comment

Today's ECB rate decision likely to be a non event but the presser will be closely watched for hints to the winding up of QE and the prospect of rate rises in the future. Rate decision at 12:45. Presser starts 13:30, usually lasts about 45 min. Will be looking for trade entries once presser has finished and price has decided on direction (if any).




Yellen's speech last night lifted the dollar with hints of an increasing number of US (small) rate rises this year.


US Dollar Basket (DFB).png190117.png

Link to comment
What to look out for from the ECB

Bond buying, Brexit and Italian banks likely to be under scrutiny

High quality global journalism requires investment. Please share this article with others using the link below, do not cut & paste the article. 

The solid, albeit unspectacular, performance of the eurozone’s economy towards the end of 2016 all but rules out any monetary policy changes at Thursday’s meeting of the European Central Bank’s governing council. But there is a growing acceptance within the bank that it is running short of ammunition to counter any fresh political or financial shocks. Expect Mario Draghi, ECB president, to face questions on the limits of the bank’s quantitative easing process and economic risks when he faces journalists at 1.30pm London time. A statement due out at 12.45pm will almost certainly confirm that the bank has left its benchmark interest rate, the main refinancing rate, at zero. The levy charged on most of the deposits parked at the eurozone’s central bank is set to stay at 0.4 per cent. Here’s what to expect from his press conference. QE terms The ECB said in the accounts of its December vote that the decision to trim its monthly bond purchases from €80bn to €60bn was partly driven by concerns they could struggle to find enough assets to buy.


High quality global journalism requires investment. Please share this article with others using the link below, do not cut & paste the article. See our T&Cs and Copyright Policy for more detail. Email ftsales.support@ft.com to buy additional rights.

Before then, Mr Draghi had suggested the ECB would carry on buying bonds until inflation was certain to hit its target of just under 2 per cent. Economists have criticised what they view as a big shift in the central bank’s stance, with some claiming the ECB is no longer as committed to its inflation target. The ECB president will face scrutiny on how long he thinks the central bank will be able to keep up its bond buying should underlying inflation remain weak. He could also say more about how the bank plans to buy some of the eurozone’s most expensive sovereign debt. Some bonds for the stronger eurozone economies, such as Germany, are so expensive that they are trading at yields lower than the ECB deposit rate of minus 0.4 per cent. Until December, the ECB had refused purchases of sovereign debt with yields below the deposit-rate floor. But a policy change allows the central bank more flexibility on what bonds it can buy. The Bundesbank, Germany’s central bank, bought bonds for yields below minus 0.4 per cent this week. Inflation If inflation were to carry on rising at the pace of past months, the ECB would be delighted: it would be on track for its inflation target and would be able to stop buying bonds by the spring.


Between November and December, annual inflation in the eurozone shot up from 0.6 per cent to 1.1 per cent. In Germany, motor of the eurozone, the shift was even more dramatic — prices rose 1.7 per cent in the year to December. The spurt will not last: it largely reflects the change in the oil price. Mr Draghi may point out that recent rises in the headline rate contrast with a lower reading for core inflation. Still, the scale of the rise in Germany has already led to a fresh round of calls from lawmakers in Berlin for the ECB to raise rates. Italian banks Italy may have averted a banking crisis late last year by approving a €20bn bailout fund for the country’s troubled financial sector, but the health of lenders remains of prime concern. Monte dei Paschi di Siena, the lender at the centre of the troubles, is set to receive €6.5bn in fresh capital from the state. Agreeing the terms of the bailout is set to take Italy and Brussels around a month, to ensure compliance with EU rules on state involvement in bank rescues. Before then, the ECB is set to issue an opinion on the €20bn fund. Mr Draghi could come under fire for the central bank’s decision to raise the figure for the amount of precautionary capital that it thinks MPS needs from €5bn to €8.8bn. Italian critics accused the ECB of a lack of transparency and failing to do enough to explain the decision (Banca d’Italia has since published this guidance). The US Donald Trump’s pledge to slap a 35 per cent tariff on BMW if it exports from plants in Mexico to the US have stirred concerns in Germany that the incoming US president will damage the country’s business model. Mr Trump has also started to question how helpful the stronger dollar is for the US, threatening to remove an advantage for eurozone manufacturers — though it may be difficult for Mr Trump to reverse the currency’s gains at a time when the US Federal Reserve is alone among the main central banks in raising rates. Brexit One big implication of the UK’s intention to quit the single market is on the clearing of payments denominated in euros, much of which takes place in London. The ECB has in the past pushed for oversight, calling for big clearing houses to decamp to the currency area, but lost a court case at the ECJ in 2015. Officials in Frankfurt and Brussels may make a fresh push for euro clearing to move to the eurozone, perhaps on the grounds that business in London will no longer fall under the scope of EU law. Mr Draghi may not want to say anything on the matter on Thursday — but the rules of where euro clearing takes place could form part of any post-Brexit deal.


18 molesworth road FLAT 1 BATHROOM.png

Link to comment

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • General Statistics

    • Total Topics
    • Total Posts
    • Total Members
    • Most Online
      10/06/21 10:53

    Newest Member
    Joined 27/07/21 15:11
  • Posts

    • GlaxoSmithKline Q2 revenue is expected to show revenue growth from newer drugs partially offset by increased generic competition in older drugs. Source: Bloomberg   Shares GlaxoSmithKline Price Revenue Vaccine Earnings before interest, taxes, depreciation and amortization  Shaun Murison | Senior Market Analyst, Johannesburg | Publication date: Tuesday 27 July 2021  When is GlaxoSmithKline earnings date? The GlaxoSmithKline (GSK) earnings release date is scheduled for the 28 July 2021. The scheduled results will cover the groups second quarter and half-year earnings.   GSK results preview: What does the street expect? While GlaxoSmithKline (in partnership with Sanofi Pasteur) look to stage three trials of their Covid-19 vaccine, the company has not yet released a vaccine to market. The global rollout of Covid-19 vaccines (by competitors) looks to have disrupted the course of other vaccine programmes in key markets such as the US and the UK for GSK. Revenue for second quarter (Q2) 2021 is expected to be bolstered by sales of newer drugs in the respiratory and HIV segments, with a partial offset from older drugs which are finding increased competition through generic offerings. In terms of the upcoming results, a mean of analyst estimates compiled by Refinitiv data arrive at the following: Revenue $10.433 billion (+10.27%) year on year (YoY) Earnings before interest tax depreciation amortisation (EBITDA) $2.855 billion (-8.91% YoY) Earnings per share (EPS) $0.51 (+10.87% YoY) How to trade the GlaxoSmithKline results   Source: Refinitiv   A Refinitiv poll of analyst ratings arrive have a long term consensus rating of ‘buy’ for GlaxoSmithKline with a target price $47.87. GlaxoSmithKline (ADR) share price: technical analysis   Source: IG The share price of GlaxoSmithKline continues to trade in an uptrend which has been in place since the beginning of March 2021. The price has however started to correct from near term highs. The correction sees the price now testing support at the 38.85 level. Traders looking for long entry might prefer to see a bullish price reversal around current levels accompanied by a sharper move out of oversold territory by the Stochastic oscillator. In this scenario, the recent high at 40.55 would become the initial resistance target, while a close below 38.35 could be used as a stop loss consideration for the trade. However should a bullish price reversal not manifest and we see the price move to close below both the 38.85 and 38.35 support levels, this could instead be a suggestion that the uptrend has failed and perhaps a new downtrend for the share price is forming. In Summary GSK reports Q2 2021 results on the 28 July Q2 revenue of $10.433 billion (+10.27% YoY) is expected Q2 EBITDA of $2.855 billion (-8.91% YoY) are expected EPS $0.51 (+10.87% YoY) in the Q2 are expected The average long term broker rating for GSK is a ‘buy’ The share price of GSK is testing support as it finds itself in a short-term correction of a longer-term uptrend
    • Alibaba continues to enjoy strong revenue and customer growth, but the decline in its stock price reflects a bleaker outlook thanks to the actions of the Chinese government. Source: Bloomberg   Shares Alibaba Group China Investor IPO Price  Chris Beauchamp | Chief Market Analyst, London | Publication date: Tuesday 27 July 2021    When is Alibaba’s earnings date? Alibaba reports earnings on 3 August, covering its fiscal first quarter (Q1). Alibaba earnings – what to expect Alibaba is expected to report revenue of $32 billion, with earnings per share of $2.24. Alibaba continues to enjoy excellent growth, achieving one billion customers in the 2021 financial year (FY2021), with the vast majority of these based in China. Profit margins and revenues have risen at a steady pace in every year since 2013, at 10% and 23% respectively. However, for Chinese tech shares such as Alibaba, the main concern is no longer business performance, but the attitude of the Chinese government instead. The cancellation of the Ant Financial initial public offering (IPO) and the current clampdown on tutoring stocks points towards a much more restrictive approach to the private sector. As many could have predicted, the culture clash between free market capitalism and the controlling instincts of the Chinese Communist Party has begun anew, with the Party determined to rein in the perceived excesses of the free market. This is a situation unfamiliar to many investors, unused to the impact of government interference on most companies except in relatively isolated circumstances, and accounts for the underperformance of Chinese shares, with Alibaba no exception. Find out more on how to buy, sell, and short Alibaba shares Alibaba broker ratings A total of 17 analysts currently rate Alibaba as a ‘strong buy’, with 30 more at ‘buy’. Three analysts have a ‘hold’ rating, and only one ‘sell’. Alibaba stock – technical analysis The direction in Alibaba stock is clear for the time being. Rallies have been regularly sold, with the latest bounce in late June running into the 100-day simple moving average (SMA), currently 22,225. With the macro outlook so unfavourable the stock continues to reflect investor caution, so it looks like further declines are on the cards as the price targets 18,000 and lower.   Source: ProRealTime A solid business, but outlook continues to darken Alibaba has plenty to commend it from a fundamental perspective, but with Beijing adopting an activist position the stock continues to decline. Investors might argue that this means Alibaba is becoming a bargain, but traders will want to see a turnaround in the price, which is unlikely to happen unless the Chinese government reduces its interventions.
    • EUR/USD, GBP/USD and NZD/USD weaken from Fibonacci resistance EUR/USD, GBP/USD and NZD/USD turn lower after posting a deep 76.4% Fibonacci retracement.   Forex NZD/USD EUR/USD GBP/USD Pound sterling Euro    Joshua Mahony | Senior Market Analyst, London | Publication date: Tuesday 27 July 2021  EUR/USD turning lower from latest retracement EUR/USD has managed to post yet another 76.4% Fibonacci retracement, with the pair heading lower once again. This highlights how the trend seen over the course of the past two months remains worth following. While the trend is very shallow in nature, that does bring a higher likeliness of a deep retracement. As such, a bearish outlook holds from here, with a push up through the prior swing-high of $1.183 required to negate that downside bias. Source: ProRealTime GBP/USD turning lower after 76.4% retracement GBP/USD has started to lose ground in early trade today, following the rally into the 76.4% Fibonacci resistance level at $1.383. With a wider bearish trend playing out over recent months, there is a good chance we see further downside from here. A rise up through the $1.391 level would be required to negate that outlook. Source: ProRealTime NZD/USD slumps after deep pullback NZD/USD has similarly turned lower after a 76.4% Fibonacci retracement yesterday. The wider downtrend points towards such a move coming into play, with a rise through $0.7045 required to negate that bearish outlook. Until then, further weakness looks likely from here. Source: ProRealTime
  • Create New...